Page last updated: 2024-08-26

norcantharidin and Leukemia, T-Cell

norcantharidin has been researched along with Leukemia, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YJ; Chou, CH; Kuo, CD; Liao, HF; Wang, FW	1

Other Studies

1 other study(ies) available for norcantharidin and Leukemia, T-Cell

Article	Year
Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production. Toxicology in vitro : an international journal published in association with BIBRA, 2011, Volume: 25, Issue:1 Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Calcineurin; Carcinogens; Cell Cycle; Cell Survival; Down-Regulation; G2 Phase; Humans; Interleukin-2; Interleukin-8; Jurkat Cells; Leukemia, T-Cell; MAP Kinase Signaling System; Phosphoric Monoester Hydrolases; Tumor Necrosis Factor-alpha; Up-Regulation	2011

Article

Year

Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production.

Toxicology in vitro : an international journal published in association with BIBRA, 2011, Volume: 25, Issue:1

Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Calcineurin; Carcinogens; Cell Cycle; Cell Survival; Down-Regulation; G2 Phase; Humans; Interleukin-2; Interleukin-8; Jurkat Cells; Leukemia, T-Cell; MAP Kinase Signaling System; Phosphoric Monoester Hydrolases; Tumor Necrosis Factor-alpha; Up-Regulation

2011